Travere Therapeutics, Inc. (TVTX)
40.83
+1.29
(+3.26%)
USD |
NASDAQ |
Apr 17, 16:00
40.80
-0.03
(-0.07%)
After-Hours: 20:00
Travere Therapeutics Enterprise Value : 3.653B for April 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Revolution Medicines, Inc. | 27.98B |
| ICU Medical, Inc. | 4.152B |
| Tandem Diabetes Care, Inc. | 1.529B |
| iRhythm Holdings, Inc. | 4.110B |
| Ligand Pharmaceuticals, Inc. | 4.176B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.99M |
| Revenue (Quarterly) | 129.69M |
| Total Expenses (Quarterly) | 151.68M |
| EPS Diluted (Quarterly) | -0.2435 |
| Gross Profit Margin (Quarterly) | 84.05% |
| Profit Margin (Quarterly) | -16.95% |
| Earnings Yield | -1.48% |
| Normalized Earnings Yield | -1.477 |